In regards to #investments stimulating #innovation: have we got the whole macro perspective in #balance? Or are there other ways we've yet to implement? Read more: https://t.co/veKCw4FE0G
In regards to #investments stimulating #innovation: have we got the whole macro perspective in #balance? Or are there other ways we've yet to implement? Read more: https://t.co/veKCw4F6b8
Many people around the world don't realise what a #mentalhealth indication is and that there are #therapies available to help. Read more: https://t.co/lz3NV8Y0zB #biotech#investment
Many people around the world don't realise what a #mentalhealth indication is and that there are #therapies available to help. Read more: https://t.co/lz3NV8XsK3 #biotech#investment
Scared money pulls away from #investments when #global turmoil occurs—if history is any indication, another hit could be around the corner, and it will have another impact on the #lifesciences.
Read more: https://t.co/YFGpnVQB9e
#biotech#recruitment
Thanks @leesasoulodre for a great article and for your insights. #venturecapital is pivotal to successful entrepreneurs. Supporting and working with them through good and tough times even moreso.
#venturecapital#venturebuildin…https://t.co/c5qpG5GW19 https://t.co/cwHonvWucF
There are endless opportunities if the #medical field can engage with #crypto whales in MENA markets. The tricky part is doing it without tarnishing their credibility.
Read more: https://t.co/LDBwPwaoHs
#biotech#recruitment
#Stocks will continue to struggle from the #biotech bubble burst, but the companies with quality design behind them will not. Data is the key factor.
Read more: https://t.co/DPIYLR0Soj
#precisionexecutivesearch
#Stocks will continue to struggle from the #biotech bubble burst, but the companies with quality design behind them will not. Data is the key factor.
Read more: https://t.co/DPIYLR0kyL
#precisionexecutivesearch
Despite all that the #InflationReductionAct has accomplished since Fall 2022, it was a generally absent topic at the @JPMorgan Health Conference...
Read more: https://t.co/8ocpQayavA
#investors#biotech
Until late 2021, #Biotech companies were engaging with #investors at earlier stages than ever. But all good things come to an end when the biotech market #crashed.
Read more: https://t.co/SP4ZcYMTHq
#precisionexecutivesearch
Until late 2021, #Biotech companies were engaging with #investors at earlier stages than ever. But all good things come to an end when the biotech market #crashed.
Read more: https://t.co/SP4ZcYMlRS
#precisionexecutivesearch
Certain industries grew exponentially during the #COVID pandemic, it reminds one of war stimulating the economy and begs the question of whether COVID can do the same.
Read more: https://t.co/FbXU0o2pAO
#biotech#recruitment
During COVID, the number of reported #mentalhealth cases grew because #Gen Z and #Millennials were stuck at home suffering—but they were finally raising their hands for help.’
Read more: https://t.co/lz3NV8XsK3
#recruitment
Due to #COVID and the conflict in #Ukrainian, 2-3 year-long #biotech projects were suddenly expected to take 4-5 years instead, disrupting periods of exclusivity for #investors who watched the seconds and dollars tick away.
Read more: https://t.co/YFGpnVR8YM
Due to #COVID and the conflict in #Ukrainian, 2-3 year-long #biotech projects were suddenly expected to take 4-5 years instead, disrupting periods of exclusivity for #investors who watched the seconds and dollars tick away.
Read more: https://t.co/YFGpnVQB9e
What is the damage of #crypto's rise and fall going to be for #biotech? Is it going to be spread? Crypto's damage could knock on other asset classes.
Read more: https://t.co/LDBwPwaWx0